US SB2387 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on July 31 2019 - 25% progression, died in committee
Action: 2019-07-31 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 31 2019 - 25% progression, died in committee
Action: 2019-07-31 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to establish a process by which reasonable drug prices may be determined, and for other purposes.
Title
We PAID Act We Protect American Investment in Drugs Act
Sponsors
Sen. Chris Van Hollen [D-MD] | Sen. Rick Scott [R-FL] |
History
Date | Chamber | Action |
---|---|---|
2019-07-31 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. |
Subjects
Business ethics
Business records
Civil actions and liability
Competition and antitrust
Congressional oversight
Government ethics and transparency, public corruption
Government information and archives
Government studies and investigations
Health
Health care costs and insurance
Health programs administration and funding
Health technology, devices, supplies
Inflation and prices
Intellectual property
Licensing and registrations
Medical research
Prescription drugs
Public contracts and procurement
Research administration and funding
Research and development
Retail and wholesale trades
Tax-exempt organizations
Business records
Civil actions and liability
Competition and antitrust
Congressional oversight
Government ethics and transparency, public corruption
Government information and archives
Government studies and investigations
Health
Health care costs and insurance
Health programs administration and funding
Health technology, devices, supplies
Inflation and prices
Intellectual property
Licensing and registrations
Medical research
Prescription drugs
Public contracts and procurement
Research administration and funding
Research and development
Retail and wholesale trades
Tax-exempt organizations
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/senate-bill/2387/all-info |
Text | https://www.congress.gov/116/bills/s2387/BILLS-116s2387is.pdf |